Twentyeight Health, the leading digital-first women’s healthcare platform delivering convenient, affordable, and stigma-free reproductive and sexual care in 43 states, has successfully secured a sum worth $10 million in Series A financing.
Led by Seae Ventures, the round saw further participation coming from the likes of Impact America Fund, The Social Entrepreneurs’ Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures, each one helping to bring the company’s total funding, till date, to a sum of $25 million. Alongside the financing, Twentyeight Health also took this opportunity to unveil partnerships with leading Medicaid insurers, including Aetna, AmeriHealth, and Molina.
Markedly enough, the development in question arrives on the back of a surge in user interest following the results of the November 5th presidential election. This surge included a 52% jump in overall conversion, a 10% increase in website traffic, and almost double the growth in emergency contraception sales.
The financing round also comes shortly after Twentyeight suppressed 100,000 users in October 2024, bolstered by a partnership with Converge in Mississippi, and patient asset acquisitions of SimpleHealth, as well as a portion of The Pill Club
The raise also treads up a long distance to reinforce what Twentyeight Health has been able to achieve since arriving on the scene back in 2018. You see, from that moment onwards, the company has established a comprehensive drive to support women in underserved, difficult-to-reach communities with approachable reproductive and sexual health services.
“45% of American women seeking reproductive health services face significant challenges in accessing care, especially the 19 million living in contraceptive and maternity care deserts where options are few,” said Bruno Van Tuykom, CEO and Co-Founder of Twentyeight Health. “Our new funding and payer partnerships will bridge this gap, helping women receive the essential care they need, regardless of geography, income, race, age, or coverage status. At an inflection point for women’s health, we are prepared to meet the moment by continuing to invest in our user experience and expanding our reach nationwide.”
Talk about the same on a slightly deeper level, we begin from the fact that it has reached a point, where Twentyeight now accepts almost every commercial and Medicaid plan. As over half of the company’s users make less than $20,000 per year, it leaves them no option but to rely on services that accept Medicaid. In response, Twentyeight Health leverages its strong network of payer partnerships to deliver, most of the times, care with $0 co-pay and $0 prescriptions. In case that wasn’t enough, the company has planned many more of such partnerships for 2025.
Next up, we must get into Twentyeight Health’s comprehensive family planning, maternity, and sexual health resources. The company’s services, at the moment, cover access to multiple birth control options, abortion pills, the “morning after” pill, herpes treatments, and pregnancy tests, as well as condoms, menstrual pads and tampons, prenatal vitamins, and more. Here, too, Twentyeight has planned a significant expansion for 2025.
Another detail worth a mention here is rooted in how all of Twentyeight Health’s resources are actually designed to aid the case of underserved communities. To expand upon that, three in Twentyeight Health users are considered underserved, two in five do not see a Primary Care Provider outside of the platform, and nearly three in five identify as people of color. In fact, before joining the company’s ecosystem, 65% of users did not even have access to birth control.
Complementing these specialized set of services is Twentyeight Health’s reach. Since its launch, the company has expanded its reach to 43 states, including Florida, Texas, Nevada, and Ohio. Not just that, it also covers 93% of American women across these 43 states.
“Raising $10 million in this economic climate is no small feat, reflecting both the resilience and relevance of Twentyeight Health’s mission,” said Arianne Kidder, Partner at Seae Ventures. “With Medicaid spending $200 billion annually on women’s health for reproductive age women, we see real potential in the company’s platform and approach. But this isn’t just about the market opportunity; it’s about backing a company tackling an urgent problem in a smart, scalable, quality-driven way.”